WAY-629 is a 5-HT_2C agonist that reduces feeding behavior when administered to rats. It was used as a starting point for developing more potent and selective 5-HT_2C agonists aimed at treating

obesity Obesity is a medical condition, sometimes considered a disease, in which excess body fat has accumulated to such an extent that it may negatively affect health. People are classified as obese when their body mass index (BMI)—a person's ...

References

{{Serotonergics Anorectics Carbazoles Benzodiazepines Serotonin receptor agonists Heterocyclic compounds with 4 rings